rss
Eur J Hosp Pharm 19:537 doi:10.1136/ejhpharm-2012-000224
  • Country focus: Denmark

Drug manufacturing in Danish hospital pharmacies

  1. Inger Bjeldbak-Olesen
  1. The Hospital Pharmacy, Region Zealand, Roskilde, Denmark
  1. Correspondence to Inger Bjeldbak-Olesen, The Hospital Pharmacy, Region Zealand, Køgevej 7-13, DK-4000 Roskilde, Denmark; ibo{at}regionsjaelland.dk
  • Received 12 September 2012
  • Accepted 14 September 2012
  • Published Online First 17 October 2012

Danish hospital pharmacies (known collectively as SAD) have a long tradition of manufacturing drugs for hospitals and some hospital pharmacies still maintain large scale production. Seventy-eight of these products have marketing authorisation. Traditionally, the products are mainly large and small volume parenterals, for example, fluids for infusion or injection, some of which have no alternatives on the Danish market. Since the five Danish regions were established in 2007, the pharmaceutical organisation Amgros has held the marketing authorisations for these SAD products.

The hospital pharmacies also produce many …

EJHP blog

Analysis and discussion of the latest news, research findings and policy developments in hospital pharmacy.

Visit the blog >>

Free Sample

This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of EJHP.

View free sample issue >>

Email alerts

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Navigate This Article